An update on the status of dosing for Spinraza across the United States included the following information:
- As of October 2018, ~2,700 patients have been dosed
- 159 sites in 44 states and DC are listed on Cure SMA’s website
- Globally, ~6,000 patients have been dosed
Additionally, an update was given on the status of AVXS-101, now known as ZOLGENSMA. An overview of recruiting clinical trials was also presented as part of the webinar.
Thank you to everyone who tuned in and sent in their questions!
For more information about Spinraza, visit www.curesma.org/Spinraza.
For more information about ongoing SMA clinical trials, visit our Trials Currently Recruiting page.